STE

STERIS plc

Healthcare
210.19 +0.43 +0.20% Market Closed
2026-06-03 • USD

Key Metrics

Market Cap 20.52B
EV —
Shares Out 97.60M
Revenue (ttm) 5.94B
Net Income 782.30M
Beta —
P/E 26.38
Forward P/E —
EPS (ttm) $7.93
P/S 3.48
P/B 2.87
P/FCF —
P/C —
EV/Sales —
EV/EBITDA —
ROA 7.29%
ROE 10.89%
ROIC 8.91%
Gross Margin 44.25%
Oper. Margin 18.56%
Profit Margin 13.18%
Debt/Eq 0.29
LT Debt/Eq 20.15%
Quick Ratio —
Current Ratio 2.09
Book/sh 73.15
Cash/sh —
Div Yield 1.14%
Div TTM $2.40
Payout Ratio 30.26%
SMA20 -1.21%
SMA50 -3.37%
SMA200 -12.8%
Volume 856,600
Avg Volume 848.83K
Rel Volume —
Perf Week -1.19%
Perf Month -1.31%
Perf Quarter -11.87%
Perf Half Y -20.16%
Perf YTD -17.09%
Perf Year -13.71%
Perf 3Y 2.01%
Perf 5Y 8.56%

Factor Lens

Seasonal Performance

Dividends

Per-share amounts adjusted for stock splits.

Last Dividend $0.6300
TTM Yield 1.14%
TTM Amount $2.40
Payout Ratio 30.26%
3-Yr Growth (CAGR) 9.68%
5-Yr Growth (CAGR) 8.99%

Last 12 Payouts

Period Ex-Date Amount / Share
Q3 2025 ~2025-12-31 $0.6300
Q2 2025 ~2025-09-30 $0.6300
Q1 2025 ~2025-06-30 $0.5700
Q4 2024 ~2025-04-01 $0.5700
Q3 2024 ~2024-12-31 $0.5700
Q2 2024 ~2024-09-30 $0.5700
Q1 2024 ~2024-06-30 $0.5200
Q4 2023 ~2024-03-31 $0.5200
Q3 2023 ~2023-12-31 $0.5200
Q2 2023 ~2023-09-30 $0.5200
Q1 2023 ~2023-06-30 $0.4700
Q4 2022 ~2023-04-01 $0.4700

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. The company operates through three reportable business segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment provides comprehensive offerings for healthcare providers worldwide, including consumables (cleaning chemistries, endoscopy accessories), capital equipment (sterilizers, surgical tables), and services (equipment maintenance, instrument repair, outsourced reprocessing). The AST segment supports medical device and pharmaceutical manufacturers through contract sterilization and laboratory testing services via a global network of facilities. The Life Sciences segment provides products and services for biopharmaceutical and medical device manufacturing facilities, including pharmaceutical detergents, sterilizers, washers, and vaporized hydrogen peroxide systems. The company's products and services are sold globally to healthcare providers, medical device manufacturers, and pharmaceutical companies, with revenues derived primarily from these customer bases.

Name
STERIS plc
Industry
Medical Instruments & Supplies
CEO
Daniel A. Carestio · President and Chief Executive Officer
Employees
14,250 as of 2025-03-31
IPO Date
2019-01-31
Phone
(353) 1 232-2000
Address
70 Sir John Rogerson's Quay, Dublin, D02 R296 2
Website
www.steris.com

Key Executives

Name Title FY Pay
Daniel A. Carestio President and Chief Executive Officer —

Latest News